drugset
drugset / Trial / NCT03914118

Modafinil to Prevent Postoperative Cognitive Decline

NCT03914118 ↗

Phase 2 Completed 137 enrolled The Cooper Health System
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Postoperative cognitive dysfunction is a well-recognized complication of surgery. The aim of the study is to investigate whether cognitive dysfunction is reduced by the use of modafinil as shown by neurocognitive testing.The treatment effects will be evaluated compared to placebo as well as a non-surgical group.

Timeline

Start
2008-01-01
Primary completion
2013-01-31
Completion
2013-01-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Modafinil Small molecule 200 mg —

Indications

No indication recorded.